Search results for: Health Policy and Regulation
Filter search results
The Economics of Health in a Shifting Climate: Insights from the 2023 Annual Lecture
26 September 2023
As part of OHE’s charitable purpose to educate and inform health policymakers and the public, the OHE Annual Lecture is an opportunity to highlight urgent and important issues facing health…
The Trump Administration’s US Drug Pricing Proposal – What will happen next?
12 June 2025
…and design of the US healthcare system. This complexity is multi-factorial, with its mix of public and private providers, insurers and funders, and the multiple stakeholders and intermediaries involved in…
The value of fast diagnostics in time-critical infections
20 April 2026
…Japan, the United Kingdom, and the United States) and incorporates expert‑validated clinical inputs, country‑specific cost data, and conservative assumptions. The findings show meaningful health gains, substantial cost savings, and consistent…
OHE’s AMR consultation response
21 November 2023
…across 17 criteria that cover aspects of clinical effectiveness, global and national needs, pharmacological benefits, and health system benefits. Each criterion is associated with scores and a weight (Figure 1)…
What is the impact of Uniform Pricing, Indication-Based Pricing (IBP) and alternative commercial arrangements for new pharmaceuticals in the UK NHS?
19 November 2024
…timing and topic, and its explicit relevance to this live and evolving policy question, we summarise the EEPRU paper’s analysis in this article and offer a short critique, outlining the…
Around The World in HTAs: Türkiye – The bumpy road toward transformation
31 January 2024
…health workers, especially nurses and doctors. The uneven distribution of specialists exacerbates regional disparities in access to healthcare. The Turkish health system is highly consolidated under the Ministry of Health…
Does the New CBO Report Change Anything?
15 September 2021
…areas, no account for how science and therefore the cost and risk of R&D has changed, and no measure of the impact on the health of the population. From the…
Breaking the European Deadlock: Part 2 – Transferable Exclusivity Vouchers – Effective Pull Incentive or a Policy Distraction?
4 January 2024
…be low. Benefits and weaknesses of TEVs and of the European Commission’s proposals The TEV proposal has been controversial and we set out the arguments for and against drawing on…
Office of Health Economics latest research estimates 20 people a day die in unrelieved pain in the UK in the last 3 months of their lives
26 November 2024
…of our research is at the forefront of all we do. OHE provides independent and pioneering resources, research and analyses in health economics, health policy and health statistics. Our work…